Skin metabolism in transdermal therapeutic systems

Skin Pharmacology and Physiology

Volumn 18, Issue 4, 2005, Pages 153-159

  Hikima, T ^a,b   Tojo, K ^b   Maibach, H I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Chemical enhancer; Drug structure; Iontophoresis; Phonophoresis (ultrasound); Skin metabolism; Temperature; Transdermal therapeutic system

Indexed keywords

ALCOHOL; AMIDE; AMINE; CHOLINESTERASE INHIBITOR; ENZYME; FATTY ACID DERIVATIVE; FATTY ACID ESTER; HYDROCORTISONE DERIVATIVE; LAUROCAPRAM; LEVO GERANYLAZACYCLOHEPTAN 2 ONE; MACROCYCLIC COMPOUND; MACROGOL 400; MENTHOL; METOPROLOL; PREDNISONE; PROPRANOLOL DERIVATIVE; SALICYLAMIDE; TERPENE DERIVATIVE; TIMOLOL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MECHANISM; DRUG PENETRATION; DRUG STRUCTURE; ENVIRONMENT; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN FUNCTION; SKIN PENETRATION; STEREOCHEMISTRY; TEMPERATURE; ULTRASOUND;

ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SKIN; SKIN ABSORPTION;

EID: 20944437489     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085860     Document Type: Review

References (91)

1. Elias PM, Cooper ER, Korc A, Brown BE: Percutaneous transport in relation to stratum corneum structure and lipid composition. J Invest Dermatol 1981;76:297-301.
2. Pannatier A, Jenner P, Testa B, Etter JC: The skin as a drug-metabolizing organ. Drug Metab Rev 1978;8:319-343.
3. Lampe MA, Williams ML, Elias PM: Human epidermal lipids: Characterization and modulations during differentiation. J Lipid Res 1983;24:131-140.
4. Franz TJ, Tojo K, Shall KR, Kydonieus A: Transdermal delivery; in Kydoneius A (ed): Treaties on Controlled Drug Delivery. New York, Dekker, Inc. 1993, pp 341-421.
5. Sloan KB: Prodrugs for dermal delivery. Adv Drug Deliv Rev 1989;3:67-101.
6. Williams AC, Barry BW: Penetration enhancers. Adv Drug Deliv Rev 2004;56:603-618.
7. Sun Y: Skin absorption enhancement by physical means: Heat, ultrasound, and electricity; in Ghosh TK, Pfister WR, Yum SI (eds): Transdermal and Topical Drug Delivery Systems. Buffalo Grove, Interpharm Press, Inc, 1997, pp 327-356.
8. Redoules D, Tarroux R, Perie J: Epidermal enzymes: Their role in homeostasis and their relationships with dermatoses. Skin Pharmacol Appl Skin Physiol 1998;11:183-192.
9. Hikima T, Ohno Y, Maibach HI: Metabolism of prednisolone 21-acetate in hairless mouse skin. Skin Pharmacol Appl Skin Physiol 2001;14:203-209.
10. Ranade VV: Drug delivery systems. 6. Transdermal drug delivery. J Clin Pharmacol 1991;31:401-418.
11. Cormier MJ, Ledger PW, Amkraut A, Marty JP: Method for reducing sensitization or irritation in transdermal drug delivery and means therefor. United States Patent, Patent No 4885154, Dec 5, 1989.
12. Potts RO, McNeill SC, Desbonnet CR, Wakshull E: Transdermal drug transport and metabolism. 2. The role of competing kinetic events. Pharm Res 1989;6:119-124.
13. Gavan N, Maibach H: Effect of topical corticosteroids on the activity of superoxide dismutase in human skin in vitro. Skin Pharmacol 1997;10:309-313.
14. Lobemeier C, Tschoetschel C, Westie S, Heymann E: Hydrolysis of parabenes by extracts from differing layers of human skin. Biol Chem 1996;377:647-651.
15. Liu P, Higuchi WI, Ghanem AH, Kurihara-Bergstrom T, Good WR: Quantitation of simultaneous diffusion and metabolism of β-estradiol in hairless mouse skin: Enzyme distribution and intrinsic diffusion/metabolism parameters. Int J Pharm 1990;64:7-25.
16. Grando SS, Kist DA, Qi M, Dahl MV: Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol 1993;101:32-36.
17. Eicheler W, Dreher M, Hoffmann R, Happle R, Aumüller G: Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. Br J Dermatol 1995;133:371-376.
18. Pelletier G, Luu-The V, Huang XF, Lapointe H, Labrie F: Localization by in situ hybridization of steroid 5α-reductase isozyme gene expression in the human prostage and preputial skin. J Urol 1998;160:577-582.
19. Markova NG, Pinkas-Sarafova A, KaramanJurukovska N, Jurukovski V, Simon M: Expression pattern and biochemical characteristics of a major epidermal retinol dehydrogenase. Mol Genet Metab 2003;78:119-135.
20. Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Höltje HD, Korting MS: Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharm Res 1999;16:1386-1391.
21. Tojo K, Yamada K, Hikima T: Diffusion and metabolism of prednisolone farnesylate in the stripped skin. Pharm Res 1994;11:393-397.
22. Yamada K, Tojo K: Bioconversion of estradiol esters in the skin of various animal models in vitro. Eur J Pharm Biopharm 1997;43:253-258.
23. Hikima T, Maibach HI: Distribution of hydrolytic activity catalyze the biotransformation of prednisolone 21-acetate in human skin. Skin Pharmacol Appl Skin Physiol 2001;14:196-202.
24. Bauerovám K, Matusová D, Kassai Z: Chemical enhancers for transdermal drug transport. Eur J Drug Metab Pharmacokinet 2001;26:85-94.
25. Chattaraj SC, Walker RB: Penetration enhancer classification; in Smith EW, Maibach HI (eds): Percutaneous Penetration Enhancers. Boca Raton, CRC Press, Inc, 1995, pp 5-20.
26. Bach M, Lippold BC: Percutaneous penetration enhancement and its quantification. Eur J Pharm Biopharm 1998;46:1-13.
27. Guy RH: Current status and future prospects of transdermal drug delivery. Pharm Res 1996;13:1765-1769.
28. Yano T, Kanetake T, Saita M, Noda K: Effect of 1-menthol and dl-camphor on the penetration and hydrolysis of methyl salicylate in hairless mouse skin. J Pharmacobiodyn 1991;14: 663-669.
29. Bhatia KS, Singh J: Effect of linolenic acid/ethanol or limonene/ethanol and iontophoresis on the in vitro percutaneous absorption of LHRH and ultrastructure of human epidermis. Int J Pharm 1999;180:235-250.
30. Lee CK, Kitagawa K, Uchida T, Kim NS, Goto S: Transdermal delivery of theophylline using an ethanol/panasate 800-ethylcellulose gel preparation. Biol Pharm Bull 1995;18:176-180.
31. Comfort AR, Dinh SM, Otte J, Shevchuk I, Berner B: Enhanced transport in a therapeutic transdermal system. Biomaterials 1990;11:729-733.
32. Liu P, Higuchi WI, Song W-Q, Kurihara-Bergstrom T, Good WI: Quantitative evaluation of ethanol effects on diffusion and metabolism of β-estradiol in hairless mouse skin. Pharm Res 1991;8:865-872.
33. Hikima T, Tojo K: Effects of pemeation enhancing agents on drug metabolism in the skin. Drug Deliv Syst 1993;8:291-295.
34. Okamoto H, Hashida M, Sezaki H: Effect of 1-alkyl or 1- alkenylazacycloalkanone derivatives on the penetration of drugs with difference lipophilicities through guinea pig skin. J Pharm Sci 1991;80:39-45.
35. Bando H, Takagi T, Yamashita F, Takakura Y, Hashida M: Theoretical design of prodrug-enhancer combination based on a skin diffusion model: Prediction of permeation of acyclovir prodrugs treated with 1-geranylazacycloheptan-2-one. Pharm Res 1996;13:427-432.
36. Patil S, Singh P, Platzer CS, Maibach H: Epidermal enzymes as penetration enhancers in transdermal drug delivery? J Pharm Sci 1996;85:249-252.
37. Tojo K, Chiang CC, Chien YW: Drug permeation across the skin: Effect of penetration hydrophilicity. J Pharm Sci 1987;76:123-126.
38. Tojo K, Chiang CC, Chien YW: Influence of donor solution upon skin permeation of drug. J Chem Eng Jap 1986;19:153-155.
39. Moriearty PL, Thornton SL, Becker RE: Transdermal patch delivery of acetylcholinesterase inhibitors. Methods Find Exp Clin Pharmacol 1993;15:407-412.
40. Morimoto K, Iwakura Y, Nakatani E, Miyazaki M, Tojima H: Effect of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats. J Pharm Pharmacol 1992;44:216-218.
41. Choi HK, Flynn GL, Amidon G L: Transdermal delivery of bioactive peptides: The effect of n-decylmethyl sulfoxide, pH, and inhibitor on enkephalin metabolism and transport. Pharm Res 1990;7:1099-1106.
42. Balant LP, Doelker E, Buri P: Prodrugs for the improvement of drug absorption via different routes of administration. Eur J Drug Metab Pharmacokinet 1990;15:143-153.
43. O'Neill RC, Carless JE: Influence of side chain on the hydrolysis of some hydrocortisone. J Pharm Pharmacol 1980;32:11.
44. Higo H, Sato S, Irie T, Uekama K: Percutaneous penetration and metabolism of salicylic acid derivatives across hairless mouse skin in diffusion cell in vitro. STP Pharma Science 1995;5:302-308.
45. Hikima T, Tojo K: Binding of prednisolone and its ester prodrugs in the skin. Pharm Res 1997;14:197-202.
46. Ahmed S, Imai T, Otagiri M: Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug. Enantiomer 1997;2:181-191.
47. Zahir A, Kunta JR, Khan MA, Reddy IK: Effect of menthol on permeability of an optically active and racemic propranolol across guinea pig skin. Drug Develop Indust Pharm 1998;24:875-878.
48. Miyazaki K, Kaiho F, Inagaki A, Dohi M, Hazemoto N, Haga M, Hara H, Kato Y: Enantiometric difference in percutaneous penetration of propranolol through rat excised skin. Chem Pharm Bull 1992;40:1075-1076.
49. Ahmed S, Imai T, Otagiri M: Stereoselective hydrolysis and penetration of propranolol prodrugs: In vitro evaluation using hairless mouse skin. J Pharm Sci 1995;84:877-883.
50. Vanbever R, de Morre N, Préat V: Transdermal delivery of fentanyl by electroporation. 2. Mechanism involved in drug transport. Pharm Res 1996;13:1360-1366.
51. Sims SM, Higuchi WI, Strinivassn V: Skin alteration and convective solvent flow effects during iontophoresis. 2. Monovalent anion and cation transport across human skin. Pharm Res 1992;9:1402-1409.
52. Rols MP, Teissié J: Electropermeabilization of mammalian cells: Quantitative analysis of the phenomenon. Biophys J 1990;58:1089-1098.
53. Simonin JP: On the mechanism of in vitro and in vivo phonophoresis. J Control Release 1995;33:125-141.
54. Levy D, Kost J, Meshulam Y, Langer R: Effect of ultrasound on transdermal drug delivery to rats and guinea pig. J Clin Invest 1989;83:2074-2078.
55. Jordan BS, Harrington DT: Management of the burn wound. Nurs Clin North Am 1997;32:251-273.
56. Ogiso T, Ogiso H, Paku T, Iwaki M: Phase transitions of rat stratum corneum lipids by an electron paramagnetic resonance study and relationship of phase states to drug penetration. Biochim Biophys Acta 1996;1301:97-104.
57. Miller MW, Ziskin MC: Biological consequences of hyperthermia. Ultrasound Med Biol 1989;15:707-722.
58. Flynn GL, Behl CR, Walter KA, Gatmatitan OG, Wittkowsky A, Kurihara T, Ho NFH, Higuchi WI: Permeability of thermally damaged skin. 3. Influence of scalding temperature on mass transfer of water and n-alkanols across hairless mouse skin. Burns 1982;8:47-58.
59. Higo N, Hinz RS, Lau DT, Benet LZ, Guy RH: Cutaneous metabolism of nitroglycerin in vitro. 2. Effects of skin condition and penetration enhancement. Pharm Res 1992;9:303-306.
60. Carter EA, Tompkins RG, Babich JW, Correia J, Bailey EM, Fischman AJ: Thermal injury in rats alters glucose utilization by skin, wound, and small intestine, but not by skeltal muscle. Metabolism 1996;45:1161-1167.
61. Fadilah R, Pinkas J, Weinberger A, Lev A: Heating rabbit joint by microwave applicator. Arch Phys Med Rehabil 1987;68:710-712.
62. Baumberger PJ: Methods for the separation of epidermis from dermis and some physiologic and chemical properties of isolated epidermis. J Natl Cancer Inst 1942;2:413.
63. Scheuplein RJ: Mechanism of percutaneous absorption. 1. Routes of penetration and influence of solubility. J Invest Dermatol 1965:45:334-346.
64. Wester RC, Christoffel J, Hartway T, Poblete N, Maibach HI, Forsell J: Human cadaver skin viability for in vitro percutaneous absorption: Storage and detrimental effect of heat-separation and freezing. Pharm Res 1998;15:82-84.
65. Kassis V, Søndergaard J: Heat-separation of normal human skin for epidermal and dermal prostaglandin analysis. Arch Dermatol Res 1982;273:301-306.
66. Liu P, Higuchi WI, Ghanem AH, Good WR: Transport of β-estradiol in freshly excised human skin in vitro: Diffusion and metabolism in each skin layer. Pharm Res 1994;11:1777-1784.
67. Mukhtar H, Bickers DR: Drug metabolism in skin. Comparative activity of the mixed-function oxidases, epoxide hydrotase, and glutathione s-transferase in liver and skin of the neonatal rat. Drug Metab Dispos 1981;9:311-314.
68. Lodén M: The in vitro hydrolisis of diisopropyl fluorophosphate during penetration through human full-thickness skin and isolated epidermis. J Invest Dermatol 1985;85:335-339.
69. Shaikh NA, Ademola JI, Maibach HI: Effect of freezing and azide treatment of in vitro human skin on the flux and metabolism of 8-methoxypsoralen. Skin Dermatol 1996;9:274-280.
70. Tierney MJ, Tamada JA, Potts RO, Eastman RC, Pitzer K, Ackerman NR, Fermi SJ: The GlucoWatch biographer: A frequent automatic and noninvasive glucose monitor. Ann Med 2000;32:632-641.
71. Burnette RR, Ongpipattanakul B: Characterization of the pore transport properties and tissue alteration of exised human skin during electrophoresis. J Pharm Sci 1988;77:132-137.
72. Wang Y, Allen LV Jr, Li LC, Tu YH, Iontophoresis of hydrocortisone across hairless mouse skin: Investigation of skin alteration. J Pharm Sci 1993;82:1140-1144.
73. Inada H, Ghanem AH, Higuchi WI: Studies on the effect of applied voltage and duration on human epidermal membrane alteration/recovery and the resultant effects upon iontophoresis. Pharm Res 1994;11:687-697.
74. Monteiro-Riviere NA: Altered epidermal morphology secondary to lidocaine iontophoresis: In vivo and in vitro studies in porcine skin. Fundam Appl Toxicol 1990;15:174-185.
75. Kim A, Green PG, Rao G, Guy RH: Convective solvent flow across the skin during iontophoresis. Pharm Res 1993;10:1315-1320.
76. Pikal MJ, Shah S: Transport mechanism in iontophoresis. 2. Electroosmotic flow and transference number measurements for hairless mouse skin. Pharm Res 1990;7:213-221.
77. 7 Green PG, Hinz RS, Kim A, Szoka FC Jr, Guy RH: Iontophoresis delivery of a series of tripeptides across the skin in vitro. Pharm Res 1991;8:1121-1127.
78. Barnett SB, ter Haar GR, Ziskin MC, Nyborg WL, Maeda K: Current status of research on biophysical effects of ultrasound. Ultrasound Med Biol 1994;20:205-218.
79. Liu J, Lewis TN, Prausnitz MR: Non-invasive assessment and control of ultrasound-mediated membrane permeabilization. Pharm Res 1998;15:918-924.
80. Mitragotri S, Farrell J, Tang H, Terahara T, Kost J, Langer R: Determination of threshold energy dose for ultrasound-induced transdermal drug transport. J Control Release 2000;63:41-52.
81. Riesz P, Kondo T: Free radical formation induced by ultrasound and its biological implications. Free Radic Biol Med 1992;13:247-270.
82. Dunn F, Macleod RM: Effect of intense non-cavitating ultrasound on selected enzyme. J Acoust Soc Am 1968;44:932-940.
83. Coakly WT, Brown WT, James CJ, Gould RK: The inactivation of enzymes by ultrasonic cavitation at 20 kHz. Arch Biochem Biophys 1973;159:722-725.
84. Matthews JC, Harder WL, Richardson WK, Fisher RJ, Al-Karmi AM, Crum LA, Dinno MA: Inactivation of firefly luciferase and rat erythrocyte ATPase by ultrasound. Membr Biochem 1993;10:213-220.
85. Kondo T, Arai S, Kuwabara M, Yoshii G, Kano E: Damage in DNA irradiated with 1.2 MHz ultrasound and its effect on template activity of DNA for RNA synthesis. Radiat Res 1985;104:284-292.
86. Fuciarelli AF, Sisk EC, Thomas RM, Miller DL: Industion of base damage in DNA solutions by ultrasonic cavitation. Free Radic Biol Med 1995;18:231-238.
87. Chetverikova EP, Pashovkin TN, Rosanova NA, Sarvazyan AP, Williams AR: Interaction of therapeutic ultrasound with purified enzyme in vitro. Ultrasonics 1985;23:183-188.
88. Hedges M, Lewis M, Lunec J, Cramp WA: The effect of ultrasound at 1.5 MHz on Escherichia coli. Int J Radiat Biol 1980;37:103-108.
89. Kashkooli HA, Rooney JA, Roxby R: Effects of ultrasound on catalase and malate dehydrogenase. J Acoust Soc Am 1980;67:1798-1801.
90. Miller DL, Reese JA, Frazier ME: Single strand DNA breaks in human leukocytes induced by ultrasound in vitro. Ultrasound Med Biol 1989;15:765-771.
91. Hikima T, Hirai Y, Tojo K: Effect of ultrasound application on the skin metabolism of prednisolone 21-acetate. Pharm Res 1998;15:1680-1683.